POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,909,960 | $19,409,433 | 3.54% |
| JOHNSON & JOHNSON | 1,000,000 | $6,670,000 | 2.46% |
| BVF INC/IL | 10,563,748 | $70,460,199 | 1.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,354,122 | 1.16% |
| Boxer Capital, LLC | 2,500,000 | $16,675,000 | 0.89% |
| Pier Capital, LLC | 732,936 | $4,888,683 | 0.79% |
| Deep Track Capital, LP | 2,781,565 | $18,553,039 | 0.72% |
| PFM Health Sciences, LP | 1,613,516 | $10,762,152 | 0.51% |
| Eagle Health Investments LP | 306,142 | $2,041,967 | 0.45% |
| Onex Canada Asset Management Inc. | 772,905 | $5,155,276 | 0.40% |
| Nantahala Capital Management | 521,191 | $3,476,344 | 0.30% |
| AlphaCentric Advisors LLC | 67,400 | $449,558 | 0.26% |
| Bellevue Group AG | 2,351,160 | $15,682,237 | 0.25% |
| HighVista Strategies LLC | 69,744 | $465,192 | 0.22% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 93,700 | $624,979 | 0.19% |
| FIRETHORN WEALTH PARTNERS, LLC | 21,705 | $144,772 | 0.11% |
| Baskin Financial Services Inc. | 132,990 | $887 | 0.09% |
| Perceptive Advisors | 800,000 | $2,630,000 | 0.09% |
| PORTLAND INVESTMENT COUNSEL INC. | 20,000 | $133 | 0.06% |
| Polar Asset Management Partners Inc. | 379,700 | $2,532,599 | 0.06% |
External links
This page lists POINT BIOPHARMA GLOBAL INC's shareholders in Q3 2023. To view POINT BIOPHARMA GLOBAL INC's shareholder history, click here.